Pills progress : From purely synthetic & chemical generics to biosimilars, Indian pharma entering a new realm

For four decades, the global healthcare narrative regarding India was as predictable as it was vital: high-volume, low-cost, and chemically synthesised. India was the world’s “medicine cabinet,” filled with the affordable blue-and-white capsules that kept healthcare systems in the West from insolvency. But as the sun rises over the sprawling R&D campuses of Hyderabad’s Genome…